Skip to content
ppopderm
ppopderm
  • Projects
    • Back to Menu
    • All Projects
      • Back to Projects
      • All Projects
      • Navigation
      • Commercial
        • Back to Menu
        • M17-380 (Start-Up)
        • LTS17367 (River-AD)
        • B7981027 (Alopecia Trial)
        • M19-973 (Optimmize-2)
        • INCB – 18424-3009 (Ruxolitinib – Vitiligo)
      • Non-Commercial
        • Back to Menu
        • A-STAR
          • Back to Menu
          • Chart-AD
          • ASTAR-BIO
          • A-STAR Project team
          • Committees and collaborators
          • Information and resources for participating sites
          • Information for Participants
          • News and Publications
          • Participating centres
          • FAQ’s
        • AD Pheno-Biome
          • Back to Menu
          • AD Pheno-Biome
          • AD Pheno-Biome project team
        • Biomap (Completed)
        • DREAM TO TREAT AD
        • EAT Study (Completed)
        • Eczema Therapies (Completed)
        • The Global Atopic Dermatitis Atlas (GADA)
        • Kids in Control
          • Back to Menu
          • Mind and Skin Consortium
            • Back to Menu
            • Mind and Skin Consortium
            • Mind and Skin Consortium Project team
        • SLEEP Study
        • SECURE-AD Covid-19 atopic dermatitis study (Completed)
        • TRANS-FOODS
        • TREAT (Completed)
        • LEAD-NLP
        • CUTIE
        • CARE
  • Patient stories
  • Publicity
  • Publications
  • Core team
    • ppopderm
    ppopderm
  • Projects
    • Back to Menu
    • All Projects
      • Back to Projects
      • All Projects
      • Navigation
      • Commercial
        • Back to Menu
        • M17-380 (Start-Up)
        • LTS17367 (River-AD)
        • B7981027 (Alopecia Trial)
        • M19-973 (Optimmize-2)
        • INCB – 18424-3009 (Ruxolitinib – Vitiligo)
      • Non-Commercial
        • Back to Menu
        • A-STAR
          • Back to Menu
          • Chart-AD
          • ASTAR-BIO
          • A-STAR Project team
          • Committees and collaborators
          • Information and resources for participating sites
          • Information for Participants
          • News and Publications
          • Participating centres
          • FAQ’s
        • AD Pheno-Biome
          • Back to Menu
          • AD Pheno-Biome
          • AD Pheno-Biome project team
        • Biomap (Completed)
        • DREAM TO TREAT AD
        • EAT Study (Completed)
        • Eczema Therapies (Completed)
        • The Global Atopic Dermatitis Atlas (GADA)
        • Kids in Control
          • Back to Menu
          • Mind and Skin Consortium
            • Back to Menu
            • Mind and Skin Consortium
            • Mind and Skin Consortium Project team
        • SLEEP Study
        • SECURE-AD Covid-19 atopic dermatitis study (Completed)
        • TRANS-FOODS
        • TREAT (Completed)
        • LEAD-NLP
        • CUTIE
        • CARE
  • Patient stories
  • Publicity
  • Publications
  • Core team

    • back to top

    Footer

    • Projects

      • All Projects
        • Commercial
          • M17-380 (Start-Up)
          • LTS17367 (River-AD)
          • B7981027 (Alopecia Trial)
          • M19-973 (Optimmize-2)
          • INCB – 18424-3009 (Ruxolitinib – Vitiligo)
        • Non-Commercial
          • A-STAR
            • Chart-AD
            • ASTAR-BIO
            • A-STAR Project team
            • Committees and collaborators
            • Information and resources for participating sites
            • Information for Participants
            • News and Publications
            • Participating centres
            • FAQ’s
          • AD Pheno-Biome
            • AD Pheno-Biome
            • AD Pheno-Biome project team
          • Biomap (Completed)
          • DREAM TO TREAT AD
          • EAT Study (Completed)
          • Eczema Therapies (Completed)
          • The Global Atopic Dermatitis Atlas (GADA)
          • Kids in Control
            • Mind and Skin Consortium
              • Mind and Skin Consortium
              • Mind and Skin Consortium Project team
          • SLEEP Study
          • SECURE-AD Covid-19 atopic dermatitis study (Completed)
          • TRANS-FOODS
          • TREAT (Completed)
          • LEAD-NLP
          • CUTIE
          • CARE
    • Patient stories
    • Publicity
    • Publications
    • Core team

    Connect with King’s College London

    King's College website
    King's College London logo

    © King’s College London Paediatric & Population-Based Dermatology Research 2026

    Website by We Create Digital